Search

Search Constraints

You searched for: Author/Creator Balsa, Alejandro

Search Results

1. Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross‐Disease Meta‐Analysis of Genome‐Wide Association Studies. Issue 9 (25th August 2016)

2. Low serum calprotectin levels correlate with the presence of biological drugs after the first year of treatment in patients with rheumatoid arthritis. (3rd October 2019)

4. Biosimilar and interchangeable: Inseparable scientific concepts?. Issue 11 (4th September 2019)

5. Switching biological disease-modifying antirheumatic drugs in patients with axial spondyloarthritis: results from a systematic literature review. Issue 2 (10th October 2017)

6. Comparison of long-term efficacy between biological agents following tumor necrosis factor inhibitor failure in patients with rheumatoid arthritis: a prospective cohort study. (November 2021)

7. Association study of BAK1 gene polymorphisms in Spanish rheumatoid arthritis and systemic lupus erythematosus cohorts. Issue 2 (17th August 2011)

8. Identification of secreted phosphoprotein 1 gene as a new rheumatoid arthritis susceptibility gene. Issue 3 (21st January 2014)

9. A combined large-scale meta-analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus. Issue 1 (18th May 2016)

10. PARE0018 ENABLING PATIENT-CENTRED CARE IN RHEUMATOID ARTHRITIS AND ASSOCIATED COMORBIDITIES. (June 2019)